Safety and Efficacy Of Long-Term Open-Label Romiplostim Dosing In Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

被引：1
|
作者：
Tarantino, Michael D.
Bussel, James B.
Geddis, Amy
Guerrera, Michael F.
Ikeda, Alan K.
Nie, Kun
Eisen, Melissa
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.3530.3530
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3530
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and Efficacy of Long-Term Open-Label Dosing of Romiplostim in Thrombocytopenic Pediatric Patients (Pts) with Immune Thrombocytopenia (ITP)
    Bussel, James B.
    Tarantino, Michael D.
    Geddis, Amy
    Guerrera, Michael F.
    Ikeda, Alan K.
    Nie, Kun
    Franklin, Janet
    Eisen, Melissa
    BLOOD, 2014, 124 (21)
  • [2] Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)
    Tarantino, Michael D.
    Bussel, James B.
    Blanchette, Victor S.
    Despotovic, Jenny M.
    Bennett, Carolyn
    Raj, Ashok
    Williams, Bronwyn
    Beam, Donald
    Morales, Jaime
    Rose, Melissa J.
    Nie, Kun
    Eisen, Melissa
    BLOOD, 2015, 126 (23)
  • [3] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF ROMIPLOSTIM, ATHROMBOPOIETIN (TPO) - RECEPTOR AGONIST, IN THROMBOCYTOPENIC PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) IN AN EXTENSION STUDY
    Bussel, James
    Tarantino, Michael
    Geddis, Amy
    Guerrera, Michael
    Ikeda, Alan
    Nie, Kun
    Franklin, Janet
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 48 - 48
  • [4] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Tarantino, M.
    Bussel, J.
    Blanchette, V.
    Despotovic, J.
    Bennett, C.
    Raj, A.
    Williams, B.
    Beam, D.
    Morales, J.
    Rose, M.
    Wang, X.
    Eisen, M.
    HAEMATOLOGICA, 2016, 101 : 587 - 587
  • [5] Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
    Bussel, James
    Tarantino, Michael
    Blanchette, Victor
    Raj, Ashok
    Despotovic, Jenny
    Beam, Donald
    Roy, John
    Wang, Xuena
    Mehta, Bhakti
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S9 - S9
  • [6] Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
    Bussel, James B.
    Tarantino, Michael D.
    Blanchette, Victor S.
    Raj, Ashok
    Despotovic, Jenny
    Beam, Donald
    Roy, John
    Wang, Xuena
    Mehta, Bhakti
    Eisen, Melissa
    BLOOD, 2016, 128 (22)
  • [7] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Bussel, J.
    Tarantino, M.
    Blanchette, V.
    Raj, A.
    Despotovic, J.
    Beam, D.
    Roy, J.
    Wang, X.
    Mehta, B.
    Eisen, M.
    HAEMATOLOGICA, 2017, 102 : 294 - 294
  • [8] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF ROMIPLOSTIM, A THROMBOPOIETIN (TPO)-RECEPTOR-AGONIST, IN THROMBOCYTOPENIC PEDIATRIC PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) IN AN EXTENSION STUDY
    Tarantino, Michael
    Bussel, James
    Geddis, Amy
    Guerrera, Michael
    Ikeda, Alan
    Nie, Kun
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S46 - S46
  • [9] Final Safety and Efficacy Data of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
    Tarantino, Michael
    Bussel, James B.
    Blanchette, Victor S.
    Beam, Donald
    Roy, John
    Despotovic, Jenny M.
    Raj, Ashok
    Carpenter, Nancy
    Mehta, Bhakti
    Eisen, Melissa
    BLOOD, 2017, 130
  • [10] FINAL SAFETY AND EFFICACY DATA OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
    Tarantino, Michael
    Bussel, James
    Blanchette, Victor
    Beam, Donald
    Roy, John
    Despotovic, Jenny
    Raj, Ashok
    Carpenter, Nancy
    Mehta, Bhaki
    Eisen, Melissa
    PEDIATRIC BLOOD & CANCER, 2018, 65
12345